Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

    • Autoimmune Disorder
    • Granulomatosis With Polyangiitis